Captopril for Prevention of Contrast-Induced Nephropathy in Diabetic Patients : A Randomised Study

Indian Heart Journal

Volumn 51, Issue 5, 1999, Pages 521-526

  Gupta, Rishi K ^a   Kapoor, Aditya ^a   Tewari, Satyendra ^a   Sinha, Nakul ^a   Sharma, R K ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CREATINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; MANNITOL; PENTETATE INDIUM IN 113M; SODIUM CHLORIDE;

ACUTE KIDNEY FAILURE; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD FLOW; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEPHROPATHY; ENZYME INHIBITION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FUNCTION; MALE; NEPHROTOXICITY; RANDOMIZED CONTROLLED TRIAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD UREA NITROGEN; CAPTOPRIL; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; CORONARY DISEASE; CREATININE; DIABETES COMPLICATIONS; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; KIDNEY FAILURE, ACUTE; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M PENTETATE; TREATMENT OUTCOME;

EID: 0033509991     PISSN: 00194832     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Nuyta GD, Elseviers MM, De Broema. Health impact of renal disease due to nephrotoxicity. Toxicol Lett 1989; 46: 31-44
2. Tommaso CL. Contrast induced nephropathy in patients undergoing cardiac catheterization. Cathet Cardiovasc Diagn 1994; 31: 316-321
3. Porter GA. Contrast associated nephropathy. Am J Cardiol 1989; 64: 22E-26E
4. Davidson CJ, Hlatky M, Morrris KG, Pieper K. Cardiovascular and renal toxicity of a non-ionic radiographic contrast agent after cardiac catheterization: A prospective trial. Ann Intern Med 1989; 110: 119-124
5. Parfrey PS, Griffiths SM, Barrett BJ, Paul MD, Genge M, Withers J, Farid N, McManamon PJ. Contrast material inducd renal failure in patients with diabetes mellitus, renal insufficiency or both. N Engl J Med 1989; 320: 143-149
6. Gomes AS, Baker JD, Martin Paredero V, Dixon SM, Takiff H, Machleder HI, Moore WS. Acute renal dysfunction after major arteriography. Am J Roentgenol 1985; 145: 1249-1253
7. Solomon R, Werner C, Mann D, Elia J, Suva P. Effect of saline, mannitol and furosemide on acute decrease in renal function induced by radiocontrast agents. N Engl J Med 1994; 331: 1416-1420
8. Deray G, Faucher C, Brilet G, Benhmida M, Bletry O, Jacobs C. Acute renal failure caused by iopamidol, a nonionic low osmolar radiocontrast agent. Am J Nephrol 1991; 11: 78-79
9. Neumayer HH, Junge W, Kufner A, Wenning A. Prevention of radiocontrast media - induced nephrotoxicity by the calcium channel blocker nitrendipine: A prospective randomized clinical trial. Nephrol Dial transplant 1989; 4: 1030-1036
10. Kenneth B, Margulies KB, McKinley LJ, Allgren RL, Staus AW, Brunelt JC. Intraarterial atrial natriuretic factor attenuated radiocontrast nephropathy in humans. J Am Soc Nephrol 1991; 2: 666-667
11. Kapoor A, Sinha N, Sharma RK, Shrivastava S. Radhakrishnan S, Goel PK, Bajaj R. Use of dopamine in prevention of contrast induced acute renal failure - A randomised study. Intern J Cardiol 1996; 53: 233-236
12. Hall KA, Wong RW, Hunter GC, Camazime BM, Rappaport WA, Smyth SH, Bull DA, McIntyre KE, Bernhard VM, Misiorowski RL. Contrast induced nephrotoxicity: The effects of vasodilator therapy. J Surg Res 1992; 53: 317-320
13. Porter GA, Closter FE, Bristow JD. Sequential effects of angiography contrast agents on renal and systemic hemodynamics. Am Heart J 1971; 81: 80-89
14. Workman RJ, Shaff MI, Jackson RV, Diggs J, Frazer MG, Briscoe C. Relationship of renal hemodynamics and functional changes following intravascular contrast to the renin angiotensin system and renal prostacyclin in the dog. Invest Radiol 1983; 18: 160-166
15. Kumar S, Hull JD, Lathi S, Cohen AJ, Pletka PG. Low incidence of renal failure after angiography. Arch Intern Med 1981; 141: 1268-1270
16. Taliercio CP, Vlietstra RE, Fisher LD, Burnett JC. Risks for renal dysfunction with cardiac angiography. Ann Intern Med 1986; 104: 501-504
17. Moore RD, Stainberg EP, Powe NR, White RI Jr. Frequency and determinants of adverse reactions induced by high osmolality contrast media. Radiology 1989; 170: 727-732
18. Barrett BJ, Parfrey PS, Vavasour HM, McDonald J. Contrast nephropathy in patients with impaired renal function: High versus low osmolar media. Kidney Intern 1992; 41: 1274-1279
19. Haltas S, Billstorm A, Tejler L. Proteinuria following nephroangiography IX: Chemical and morphological analysis in dogs. Acta Radiol 1981; 22: 427-433
20. Gelman LM, Rowe JW, Coggins CH. Effects of an angiographic contrast agent on renal function. Cardiovasc Med 1979; 4: 313
21. Abu Rometi SH, Nawaz MK, Ali H. Short term effect of angiotensin-converting enzyme inhibitor enalapril in incipient diabetic nephropathy. Clin Nephrol 1989; 31: 18-21